We report a presentation in an adult with Streptococcus pyogenes bacteremia and invasive tissue disease with rhabdomyolysis, but without evidence of toxic shock syndrome or local myonecrosis. We thus investigated how this infecting strain differed from strains known to cause toxic shock syndrome.
E. M. Adams, S. Gudmundsson, D. E. Yocum, R. C. Haselby, W. A. Craig, and W. R. Sundstrom, “Streptococcal myositis,” Archives of Internal Medicine, vol. 145, no. 6, pp. 1020–1023, 1985.
View at: Publisher Site | Google ScholarK. Belani, P. Schlievert, E. L. Kaplan, and P. Ferrieri, “Association of exotoxin-producing group A streptococci and severe disease in children,” Pediatric Infectious Disease Journal, vol. 10, no. 5, pp. 351–354, 1991.
View at: Google ScholarP. Schlievert, personal communication, Department of Microbiology, University of Minnesota.
A. L. Bisno and D. L. Stevens, “Streptococcal infections in skin and soft tissues,” The New England Journal of Medicine, vol. 334, no. 4, pp. 240–245, 1996.
View at: Google ScholarP. Schlievert, “Role of superantigens in human disease,” Journal of Infectious Diseases, vol. 167, no. 5, pp. 997–1002, 1993.
View at: Google ScholarB. L. Kotzin, “Superantigens and their role in disease,” Hospital Practice, vol. 29, no. 11, pp. 59–63, 68–70, 1994.
View at: Google Scholar“Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. The Working Group on Severe Streptococcal Infections,” The Journal of the American Medical Association, vol. 269, no. 3, pp. 390–391, 1993.
View at: Publisher Site | Google ScholarA. R. Hauser, D. L. Stevens, E. L. Kaplan, and P. Schlievert, “Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome,” Journal of Clinical Microbiology, vol. 29, no. 8, pp. 1562–1567, 1991.
View at: Google ScholarD. R. Johnson, D. L. Stevens, and E. L. Kaplan, “Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis,” Journal of Infectious Diseases, vol. 166, no. 2, pp. 374–382, 1992.
View at: Google ScholarJ. M. Musser, A. R. Hauser, M. H. Kim, P. Schlievert, K. Nelson, and R. K. Selander, “Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 7, pp. 2668–2672, 1991.
View at: Publisher Site | Google ScholarB. Schwartz, R. R. Facklam, and R. F. Breiman, “Changing epidemiology of group A streptococcal infection in the USA,” The Lancet, vol. 336, no. 8724, pp. 1167–1171, 1990.
View at: Publisher Site | Google ScholarD. L. Stevens, M. H. Tanner, J. Winship et al., “Reappearance of scarlet fever toxin A among streptococci in the Rocky Mountain West: severe group A streptococcal infections associated with a toxic shock-like syndrome,” The New England Journal of Medicine, vol. 321, pp. 1–7, 1989.
View at: Google ScholarE. T. Gaworzewska and G. Coleman, “Correspondence: group A streptococcal infections and a toxic shock-like syndrome,” The New England Journal of Medicine, vol. 321, p. 1546, 1989.
View at: Google ScholarB. Stegmayr, S. Björck, S. Holm, J. Nisell, A. Rydvall, and B. Settergren, “Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects,” Scandinavian Journal of Infectious Diseases, vol. 24, no. 5, pp. 589–597, 1992.
View at: Publisher Site | Google ScholarJ. A. Mollick, G. G. Miller, J. M. Musser, R. G. Cook, D. Grossman, and R. R. Rich, “A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C,” The Journal of Clinical Investigation, vol. 92, no. 2, pp. 710–719, 1993.
View at: Publisher Site | Google ScholarM. Iwasaki, H. Igarashi, Y. Hinuma, and T. Yutsudo, “Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor,” FEBS Letters, vol. 331, no. 1-2, pp. 187–192, 1993.
View at: Publisher Site | Google ScholarA. Norrby-Teglund, D. Newton, M. Kotb, S. E. Holm, and M. Norgren, “Superantigenic properties of the group A streptococcal exotoxin SpeF (MF),” Infection and Immunity, vol. 62, no. 12, pp. 5227–5233, 1994.
View at: Google ScholarG. A. Bohach, D. J. Fast, R. D. Nelson, and P. Schlievert, “Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses,” Critical Reviews in Microbiology, vol. 17, no. 4, pp. 251–272, 1990.
View at: Publisher Site | Google ScholarD. L. Murray, D. H. Ohlendorf, and P. Schlievert, “Staphylococcal and streptococcal superantigens: their role in human disease,” ASM News, vol. 61, no. 5, pp. 229–235, 1995.
View at: Google ScholarJ. Kuby, Immunology, W. H. Freeman, New York, NY, USA, 2nd edition, 1994.
V. Hríbalová, “Streptococcus pyogenes and the toxic shock syndrome,” Annals of Internal Medicine, vol. 108, no. 5, p. 772, 1988.
View at: Google Scholar